Related Experiment Video
Updated: Mar 14, 2026
04:59
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
1.5K
Climate Change and the Switch from Pressurised Metered-Dose Inhalers to Dry Powder Inhalers: A Proportionate
Sanjeeva Dissanayake1, Jason Suggett2, Alan Kaplan3,4,5
1Certior Consulting, London, UK. sanjeeva@certiorconsulting.com.
Pulmonary Therapy
|March 12, 2026
Summary
Urgent action is needed to reduce global temperatures. This paper questions the environmental benefits of switching from pressurized metered-dose inhalers (pMDIs) to dry powder inhalers (DPIs), suggesting other measures may be more impactful.
Area of Science:
- Environmental science
- Public health
- Climate change mitigation
Background:
- Global temperature increase necessitates urgent action.
- Behavioral changes are critical for rapid emissions reduction.
- Healthcare-related emissions, particularly from inhalers, are a focus for mitigation.
Purpose of the Study:
- To evaluate the environmental rationale for transitioning from pMDIs to DPIs.
- To assess the proportionality of environmental gains versus potential impacts.
- To explore alternative measures for greater environmental impact.
Main Methods:
- Literature review and analysis of environmental impact data.
- Comparative assessment of greenhouse gas emissions from pMDIs and DPIs.
- Evaluation of the global warming potential (GWP) of hydrofluorocarbons in pMDIs.
Main Results:
- Pressurized metered-dose inhalers (pMDIs) utilize hydrofluorocarbons with high global warming potential (GWP).
- Dry powder inhalers (DPIs) offer a lower GWP alternative.
- The environmental benefit of switching from pMDIs to DPIs requires further scrutiny regarding its proportionality.
Conclusions:
- The proposed transition from pMDIs to DPIs warrants a robust evaluation of its environmental justification.
- While a valid consideration, the impact of this transition should be weighed against other potential climate mitigation strategies.
- Further research is needed to prioritize interventions for maximum environmental benefit in healthcare settings.
Related Concept Videos
01:23Inhaled Medications
952
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
952
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.0K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.0K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K